Insider · SEC Form 4 filer
Gregory Bailey
Past buys: 3 of 7 beat
Companies
Where they file as an insider
Serina Therapeutics (SER) Director Latest filing Jun 17, 2026
Biohaven (BHVN) Director Latest filing Nov 13, 2025
Track record
Did their buys beat the typical stock?
Open-market buys22
Quarters checked 6 months later7
Beat the typical stock 3 of 7
Quarters too new to check0
3 of 7 checked quarters beat the typical stock. A past record is data, not a forecast.
Biohaven (BHVN) Bought Nov 13, 2025 · $3M · 400,000 shares Beat typical Dec 31, 2025 $11.29 → Jun 30, 2026 $14.88 · +31.8% (typical stock +4.7%)
Serina Therapeutics (SER) Bought Dec 17, 2024 · $17.7K · 3,866 shares Beat typical Dec 31, 2024 $5.01 → Jun 30, 2025 $6.16 · +23.0% (typical stock −3.4%)
Biohaven (BHVN) Bought Sep 24, 2024 · $221K · 5,000 shares Behind typical Sep 30, 2024 $49.97 → Mar 31, 2025 $24.04 · −51.9% (typical stock −7.5%)
Serina Therapeutics (SER) Bought Aug 14–Sep 20, 2024 · $295K · 42,901 shares Behind typical Sep 30, 2024 $6.69 → Mar 31, 2025 $5.67 · −15.2% (typical stock −7.5%)
Serina Therapeutics (SER) Bought May 20–30, 2024 · $192K · 20,206 shares Behind typical Jun 30, 2024 $9.58 → Dec 31, 2024 $5.01 · −47.7% (typical stock +3.9%)
Biohaven (BHVN) Bought Apr 22–May 13, 2024 · $3.51M · 89,283 shares Beat typical Jun 30, 2024 $34.71 → Dec 31, 2024 $37.35 · +7.6% (typical stock +3.9%)
Biohaven (BHVN) Bought Oct 4, 2023 · $402K · 17,817 shares Behind typical Dec 31, 2023 $42.80 → Jun 30, 2024 $34.71 · −18.9% (typical stock −1.2%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.